The Indiana Myeloma Registry

Recruiting now

Conditions studied: Plasma Cell Dyscrasias

In brief

This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research

Key facts

Study ID

NCT03616483

Run by

Indiana University

People needed

2500

Starts

2018-06-18

Expected to finish

2028-06-30

Last updated by the study team

2025-11-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female patients ≥ 18 years of age at the time of informed consent
• Has been diagnosed with or is suspected to have one of the following:
• Monoclonal Gammopathy of Undetermined Significance (MGUS)
• Smoldering Multiple Myeloma
• Multiple Myeloma
• Bony or Soft Tissue Plasmacytoma
• Primary Amyloidosis

You may not qualify if…

• < 18 years of age
• Have not been diagnosed with one of the following:
• Monoclonal Gammopathy of Undetermined Significance (MGUS) b.Smoldering Multiple Myeloma c.Multiple Myeloma d.Bony or Soft Tissue Plasmacytoma e.Primary Amyloidosis

Where it is running

• Indiana University Simon Cancer Center — Indianapolis, Indiana, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.